# Can MRI Evaluate Beta-blocker Response in Portal Hypertension?

> **NCT03114813** · — · UNKNOWN · sponsor: **University of Nottingham** · enrollment: 68 (estimated)

## Conditions studied

- Liver Cirrhosis
- Portal Hypertension
- Varix, Esophageal

## Interventions

- **DRUG:** Carvedilol
- **OTHER:** MRI scan
- **PROCEDURE:** Hepatic Venous Pressure Gradient (HVPG)

## Key facts

- **NCT ID:** NCT03114813
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-07
- **Final completion:** 2024-01
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2018-05-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03114813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03114813, "Can MRI Evaluate Beta-blocker Response in Portal Hypertension?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03114813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*